John Newton | The Medical School | University of Exeter

Professor John Newton

Professor of Public Health

J.N.Newton@exeter.ac.uk

Overview

Publications

Books

Burge S, Cutler T, Dayan A, de Swiet M, Devanesan A, Foster G, Knowles J, Newton J, Oakeley H, Snell N, et al (2023). Modern Medicines from Plants: Botanical histories of some of modern medicine’s most important drugs. Abstract.

Journal articles

Bauer-Staeb C, Holleyman R, Barnard S, Hughes A, Dunn S, Fox S, Fitzpatrick J, Newton J, Fryers P, Burton P, et al (In Press). Risk of Death in England Following a Positive SARS-CoV-2 Test: a Retrospective National Cohort Study (March 2020 to September 2022).

Pearson-Stuttard J, Caul S, McDonald S, Whamond E, Newton JN (2024). Excess mortality in England post Covid-19 pandemic: implications for secondary prevention. The Lancet Regional Health - Europe, 36

Wei J, Stoesser N, Matthews PC, Khera T, Gethings O, Diamond I, Studley R, Taylor N, Peto TEA, Walker AS, et al (2024). Risk of SARS-CoV-2 reinfection during multiple Omicron variant waves in the UK general population. Nature Communications, 15(1). Abstract.

Li B, Allebeck P, Burstöm B, Danielsson A-K, Degenhardt L, Eikemo TA, Ferrari A, Knudsen AK, Lundin A, Manhica H, et al (2023). Educational level and the risk of mental disorders, substance use disorders and self-harm in different age-groups: a cohort study covering 1,6 million subjects in the Stockholm region. Int J Methods Psychiatr Res, 32(4). Abstract. Author URL.

Vihta KD, Pouwels KB, Peto TEA, Pritchard E, House T, Studley R, Rourke E, Cook D, Diamond I, Crook D, et al (2023). Omicron-Associated Changes in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Symptoms in the United Kingdom. Clinical Infectious Diseases, 76(3), E133-E141. Abstract.

Wei J, Matthews PC, Stoesser N, Newton JN, Diamond I, Studley R, Taylor N, Bell JI, Farrar J, Kolenchery J, et al (2023). Protection against SARS-CoV-2 Omicron BA.4/5 variant following booster vaccination or breakthrough infection in the UK. Nature Communications, 14(1). Abstract.

Roberts DJ, Massey V, Morris J, Verlander NQ, Saei A, Young N, Makhani S, Wilcox D, Davies G, White S, et al (2023). The effect of community water fluoridation on dental caries in children and young people in England: an ecological study. J Public Health (Oxf), 45(2), 462-469. Abstract. Author URL.

Holleyman R, Barnard S, Bauer-Staeb C, Hughes A, Dunn S, Fox S, Newton J, Fitzpatrick J, Waller Z, Deehan D, et al (2022). Adjusting Expected Deaths for Mortality Displacement During the COVID-19 Pandemic: a Model Based Counterfactual Approach at the Level of Individuals.

Wei J, Pouwels KB, Stoesser N, Matthews PC, Diamond I, Studley R, Rourke E, Cook D, Bell JI, Newton JN, et al (2022). Antibody responses and correlates of protection in the general population after two doses of the ChAdOx1 or BNT162b2 vaccines. Nat Med, 28(5), 1072-1082. Abstract. Author URL.

Pritchard E, Jones J, Vihta KD, Stoesser N, Matthews PPC, Eyre DW, House T, Bell JI, Newton PJN, Farrar J, et al (2022). Monitoring populations at increased risk for SARS-CoV-2 infection in the community using population-level demographic and behavioural surveillance. The Lancet Regional Health - Europe, 13 Abstract.

Wei J, Matthews PC, Stoesser N, Diamond I, Studley R, Rourke E, Cook D, Bell JI, Newton JN, Farrar J, et al (2022). SARS-CoV-2 antibody trajectories after a single COVID-19 vaccination with and without prior infection. Nat Commun, 13(1). Abstract. Author URL.

Wei J, Matthews PC, Stoesser N, Maddox T, Lorenzi L, Studley R, Bell JI, Newton JN, Farrar J, Diamond I, et al (2021). Anti-spike antibody response to natural SARS-CoV-2 infection in the general population. NATURE COMMUNICATIONS, 12(1). Author URL.

Wei J, Stoesser N, Matthews PC, Ayoubkhani D, Studley R, Bell I, Bell JI, Newton JN, Farrar J, Diamond I, et al (2021). Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom. Nat Microbiol, 6(9), 1140-1149. Abstract. Author URL.

Pouwels KB, House T, Pritchard E, Robotham JV, Birrell PJ, Gelman A, Vihta KD, Bowers N, Boreham I, Thomas H, et al (2021). Community prevalence of SARS-CoV-2 in England from April to November, 2020: results from the ONS Coronavirus Infection Survey. The Lancet Public Health, 6(1), e30-e38. Abstract.

Walker AS, Pritchard E, House T, Robotham JV, Birrell PJ, Bell I, Bell JI, Newton JN, Farrar J, Diamond I, et al (2021). Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time. ELIFE, 10 Author URL.

Pouwels KB, Pritchard E, Matthews PC, Stoesser N, Eyre DW, Vihta K-D, House T, Hay J, Bell JI, Newton JN, et al (2021). Effect of Delta variant on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK. NATURE MEDICINE, 27(12), 2127-+. Author URL.

Pritchard E, Matthews PC, Stoesser N, Eyre DW, Gethings O, Vihta K-D, Jones J, House T, VanSteenHouse H, Bell I, et al (2021). Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom. Nat Med, 27(8), 1370-1378. Abstract. Author URL.

Barnard S, Fryers P, Fitzpatrick J, Fox S, Waller Z, Baker A, Burton P, Newton J, Doyle Y, Goldblatt P, et al (2021). Inequalities in excess premature mortality in England during the COVID-19 pandemic: a cross-sectional analysis of cumulative excess mortality by area deprivation and ethnicity. BMJ OPEN, 11(12). Author URL.

Anderson M, Pitchforth E, Asaria M, Brayne C, Casadei B, Charlesworth A, Coulter A, Franklin BD, Donaldson C, Drummond M, et al (2021). LSE–Lancet Commission on the future of the NHS: re-laying the foundations for an equitable and efficient health and care service after COVID-19. The Lancet, 397(10288), 1915-1978.

Haneef R, Schmidt J, Gallay A, Devleesschauwer B, Grant I, Rommel A, Wyper GM, Van Oyen H, Hilderink H, Ziese T, et al (2021). Recommendations to plan a national burden of disease study. Arch Public Health, 79(1). Abstract. Author URL.

Newton JN, Griffiths C, Fitzpatrick J, Lamagni T, Campos-Matos I (2021). Sex-disaggregated data is reported by Public Health England. Lancet Glob Health, 9(8). Author URL.

McKee M, Dunnell K, Anderson M, Brayne C, Charlesworth A, Johnston-Webber C, Knapp M, McGuire A, Newton JN, Taylor D, et al (2021). The changing health needs of the UK population. Lancet, 397(10288), 1979-1991. Abstract. Author URL.

Dockrell M, Newton JN (2021). Tobacco Control Leaders Call for a Balanced Assessment of the Risks and Benefits of Nicotine Vaping. Am J Public Health, 111(9), 1570-1571. Author URL.

Walker AS, Vihta K-D, Gethings O, Pritchard E, Jones J, House T, Bell I, Bell JI, Newton JN, Farrar J, et al (2021). Tracking the Emergence of SARS-CoV-2 Alpha Variant in the United Kingdom. N Engl J Med, 385(27), 2582-2585. Author URL.

Newton JN (2021). Trends in health expectancies across Europe: Countries that are achieving compression of morbidity and those that are not. The Lancet Regional Health - Europe, 3

Newton JN (2020). Counting early deaths due to socioeconomic inequality. The Lancet Public Health, 5(1), e6-e7.

Newton JN, Dockrell M (2019). Continuing burden of tobacco-related harm: E-cigarette policy in England is evidence based and not exceptional. American Journal of Public Health, 109(11), E28-E29.

Haneef R, Gallay A, Hilderink H, Devleesschauwer B, Ziese T, Schmidt J, Newton J (2019). Development of composite indicators to monitor burden of disease across Member States. European Journal of Public Health, 29(Supplement_4).

Campos-Matos I, Stannard J, de Sousa E, O'Connor R, Newton JN (2019). From health for all to leaving no-one behind: public health agencies, inclusion health, and health inequalities. The Lancet Public Health, 4(12), e601-e603.

Steel N, Ford JA, Newton JN, Stockton D, Hughes A (2019). Health in the UK–Authors’ reply. The Lancet, 394(10201), 828-829.

Ford J, Steel N, Aasheim E, Devleesschauwer B, Gallay A, Morgan D, Schmidt J, Ziese T, Newton J (2019). Slowing improvements in life expectancy across European Economic Area countries. European Journal of Public Health, 29(Supplement_4).

Newton JN (2019). Time for the Lancet to realign with the evidence on e-cigarettes?. The Lancet, 394(10211), 1804-1805.

Steel N, Ford JA, Newton JN (2018). Changes in health in the countries of the UK and 150 English Local Authority areas 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 392, pg 1647, 2018). LANCET, 392(10158), 1628-1628. Author URL.

Steel N, Ford JA, Newton JN, Davis ACJ, Vos T, Naghavi M, Glenn S, Hughes A, Dalton AM, Stockton D, et al (2018). Changes in health in the countries of the UK and 150 English Local Authority areas 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet, 392(10158), 1647-1661. Abstract.

Newton JN (2018). Dissecting the life expectancy gap in England provides clues on how to reduce it. The Lancet Public Health, 3(12), e560-e561.

Newton JN, Dockrell M, Marczylo T (2018). Electronic cigarettes: adolescent health and wellbeing – Authors' reply. The Lancet, 392(10146).

Steel N, Ford J, Newton J, Davis A, Vos T, Naghavi M, Hughes A, Dalton A, Schmidt J, Murray C, et al (2018). Global burden of disease (GBD) 2016 subnational estimates for 150 English local authorities. European Journal of Public Health, 28(suppl_4).

Newton JN, Dockrell M, Marczylo T (2018). Making sense of the latest evidence on electronic cigarettes. The Lancet, 391(10121), 639-642.

Newton JN, Cosford P (2018). Partnerships with the alcohol industry: opportunities and risks. The Lancet, 392(10156), 1401-1402.

Newton J (2018). Public Health England has not been captured by the alcohol industry. BMJ, 363 Author URL.

Baker A, Ege F, Fitzpatrick J, Newton J (2018). Response to articles on mortality in England and Wales. J R Soc Med, 111(2), 40-41. Author URL.

Newton JN, Verne J, Dancox M, Young N (2017). 'Are fluoride levels in drinking water associated with hypothyroidism prevalence in England? a large observational study of GP practice data and fluoride levels in drinking water': Comments on the authors' response to earlier criticism. Journal of Epidemiology and Community Health, 69, 315-316.

Ellis BM, Newton JN (2017). A new public health, tiered approach to improving musculoskeletal health through physical activity provision. Journal of Public Health (United Kingdom), 39(3), 429-432.

Kassebaum NJ, Barber RM, Dandona L, Hay SI, Larson HJ, Lim SS, Lopez AD, Mokdad AH, Naghavi M, Pinho C, et al (2017). Erratum: Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1775–1812)(S0140673616314702)(10.1016/S0140-6736(16)31470-2)). The Lancet, 389(10064). Abstract.

Wang H, Bhutta ZA, Coates MM, Coggeshall M, Dandona L, Diallo K, Franca EB, Fraser M, Fullman N, Gething PW, et al (2017). Erratum: Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015 (The Lancet (2016) 388(10053) (1725–1774)(S0140673616315756)(10.1016/S0140-6736(16)31575-6)). The Lancet, 389(10064). Abstract.

Newton JN, Thompson K (2017). NHS health check: National evaluation findings and implications. CMAJ, 189(4).

Stein C, Newton J (2017). Sharing the burden: a new European Burden of Disease Network is formed. Eur J Public Health, 27(2), 191-192. Author URL.

Andermann A, Pang T, Newton JN, Davis A, Panisset U (2016). Evidence for Health I: Producing evidence for improving health and reducing inequities. Health Research Policy and Systems, 14(1). Abstract.

Andermann A, Pang T, Newton JN, Davis A, Panisset U (2016). Evidence for Health II: Overcoming barriers to using evidence in policy and practice. Health Research Policy and Systems, 14(1). Abstract.

Andermann A, Pang T, Newton JN, Davis A, Panisset U (2016). Evidence for Health III: Making evidence-informed decisions that integrate values and context. Health Research Policy and Systems, 14(1). Abstract.

(2016). Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (London, England), 388(10053), 1659-1724. Abstract.

Kassebaum NJ, Arora M, Barber RM, Brown J, Carter A, Casey DC, Charlson FJ, Coates MM, Coggeshall M, Cornaby L, et al (2016). Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1603-1658. Abstract.

Vos T, Allen C, Arora M, Barber RM, Brown A, Carter A, Casey DC, Charlson FJ, Chen AZ, Coggeshall M, et al (2016). Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1545-1602. Abstract.

Kassebaum NJ, Barber RM, Dandona L, Hay SI, Larson HJ, Lim SS, Lopez AD, Mokdad AH, Naghavi M, Pinho C, et al (2016). Global, regional, and national levels of maternal mortality, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1775-1812. Abstract.

Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM, et al (2016). Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. LANCET, 388(10053), 1459-1544. Author URL.

Wang H, Bhutta ZA, Coates MM, Coggeshall M, Dandona L, Diallo K, Franca EB, Fraser M, Fullman N, Gething PW, et al (2016). Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1725-1774. Abstract.

Lim SS, Allen K, Dandona L, Forouzanfar MH, Fullman N, Goldberg EM, Hay SI, Holmberg M, Kutz MJ, Larson HJ, et al (2016). Measuring the health-related Sustainable Development Goals in 188 countries: a baseline analysis from the Global Burden of Disease Study 2015. The Lancet, 388(10053), 1813-1850. Abstract.

Newton JN, Pebody R, Fitzpatrick J (2016). Peak in deaths in 2015 is not a complete mystery. BMJ (Online), 352

Newton JN, Briggs ADM, Murray CJL, Dicker D, Foreman KJ, Wang H, Naghavi M, Forouzanfar MH, Ohno SL, Barber RM, et al (2015). Changes in health in England, with analysis by English regions and areas of deprivation, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. The Lancet Abstract.

Young N, Newton J, Morris J, Morris J, Langford J, Iloya J, Edwards D, Makhani S, Verne J (2015). Community water fluoridation and health outcomes in England: a cross-sectional study. Community Dent Oral Epidemiol, 43(6), 550-559. Abstract. Author URL.

Newton JN (2015). Future inequalities in life expectancy in England and Wales. The Lancet, 386(9989), 115-117.

Newton JN, Young N, Verne J, Morris J (2015). Water fluoridation and hypothyroidism: Results of this study need much more cautious interpretation. Journal of Epidemiology and Community Health, 69(7), 617-618.

Newton JN, Davis A, Waterall J, Fenton KA (2014). NHS health check programme: Too early to conclude. BMJ (Online), 349

Newton J (2013). In Practice: Working with knowledge for the health of the public. PERSPECTIVES IN PUBLIC HEALTH, 133(4), 191-192. Author URL.

Murray CJL, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, Bennett D, Bernabé E, Blencowe H, Bourne R, et al (2013). UK health performance: Findings of the Global Burden of Disease Study 2010. The Lancet, 381(9871), 997-1020. Abstract.

Murray CJ, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, Bennett D, Bernabé E, Blencowe H, Bourne R, et al (2013). UK health performance: findings of the Global Burden of Disease Study 2010. The Lancet

Garner SE, Eady A, Bennett C, Newton JN, Thomas K, Popescu CM (2012). Minocycline for acne vulgaris: Efficacy and safety. Cochrane Database of Systematic Reviews, 2012(8). Abstract.

Garner SE, Eady A, Popescu CM, Newton J, Po ALW (2011). Cochrane Review: Minocycline for acne vulgaris: efficacy and safety. Evidence-Based Child Health a Cochrane Review Journal, 6(5), 1440-1544.

Simpson CR, Newton J, Hippisley-Cox J, Sheikh A (2009). Trends in the epidemiology and prescribing of medication for eczema in England. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 102(3), 108-117. Author URL.

Simpson CR, Newton J, Hippisley-Cox J, Sheikh A (2008). Incidence and prevalence of multiple allergic disorders recorded in a national primary care database. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 101(11), 558-563. Author URL.

Sheikh A, Hippisley-Cox J, Newton J, Fenty J (2008). Trends in national incidence, lifetime prevalence and adrenaline prescribing for anaphylaxis in England. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 101(3), 139-143. Author URL.

Ghouri N, Hippisley-Cox J, Newton J, Sheikh A (2008). Trends in the epidemiology and prescribing of medication for allergic rhinitis in England. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 101(9), 466-472. Author URL.

Elliott JA, Hanna S, Newton JN, Elliott AMS, Cooley GE (2006). Elimination of orientation in perfluorinated lonomer membranes. POLYMER ENGINEERING AND SCIENCE, 46(2), 228-234. Author URL.

Garner SE, Eady EA, Popescu C, Newton J, Li WA (2003). Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev(1). Abstract. Author URL.

Klassen A, Newton J, Goodacre T (2001). The Derriford Appearance Scale (DAS-59). Br J Plast Surg, 54(7), 647-648. Author URL.

Newton JN, Roberts CJ, Canning C (2000). Corneal opacities after cataract surgery with hypromellose. Lancet, 355(9200). Abstract.

Klassen AF, Newton JN, Mallon E (2000). Measuring quality of life in people referred for specialist care of acne: Comparing generic and disease-specific measures. Journal of the American Academy of Dermatology, 43(2 I), 229-233. Abstract.

Garner SE, Eady EA, Popescu C, Newton J, Li Wan Po A (2000). Minocycline for acne vulgaris: efficacy and safety. Cochrane Database Syst Rev(2). Abstract. Author URL.

West E, Barron DN, Dowsett J, Newton JN (1999). Hierarchies and cliques in the social networks of health care professionals: Implications for the design of dissemination strategies. Social Science and Medicine, 48(5), 633-646. Abstract.

Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY (1999). The quality of life in acne: a comparison with general medical conditions using generic questionnaires. BRITISH JOURNAL OF DERMATOLOGY, 140(4), 672-676. Author URL.

Volmink JA, Newton JN, Hicks NR, Sleight P, Fowler GH, Neil HAW (1998). Coronary event and case fatality rates in an English population: Results of the Oxford myocardial infarction incidence study. Heart, 80(1), 40-44. Abstract.

Newton JN (1998). The epidemiology of coronary heart disease and HRT what are the contentious issues?. Menopause International, 4(4), 135-142. Abstract.

West E, Newton J (1997). Clinical guidelines. BMJ, 315(7104). Author URL.

Newton JN (1997). How cost-effective is oral isotretinoin?. Dermatology, 195(1), 10-14. Abstract.

Newton JN, Holton S (1997). Incidence of myocardial infarction is affected by deprivation in Buckinghamshire too [8]. British Medical Journal, 314(7092).

Newton JN, Mallon E, Klassen A, Ryan TJ, Finlay AY (1997). The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. British Journal of Dermatology, 137(4), 563-567. Abstract.

Newton J, Seagroatt V, Goldacre M (1996). Comparing measures of variation. J Epidemiol Community Health, 50(2). Author URL.

Newton J, West E (1996). Evidence-based medicine and compassion. Lancet, 347(9018). Author URL.

Newton J, Redburn J (1995). Accuracy of local data on skin cancer. BMJ, 311(6998). Author URL.

Newton JN, Redburn J (1995). Incidence of melanoma in four English counties, 1989-92. BMJ, 310(6978).

Newton JN, Henderson J, Goldacre MJ (1995). Waiting list dynamics and the impact of earmarked funding. BMJ, 311(7008). Abstract.

Newton JN, Seagroatt V, Goldacre M (1994). Geographical variation in hospital admission rates: an analysis of workload in the Oxford region, England. Journal of Epidemiology and Community Health, 48(6), 590-595. Abstract.

Newton J (1994). Guidelines for prior publication in a letter of findings from a substantive paper. Journal of Public Health, 16(2).

Newton J, Goldacre M (1994). How many patients are admitted in districts other than their own, and why?. J Public Health Med, 16(2), 159-164. Abstract. Author URL.

Williams MH, Newton JN, Frankel SJ, Braddon F, Barclay E, Gray JAM (1994). Prevalence of total hip replacement: How much demand has been met?. Journal of Epidemiology and Community Health, 48(2), 188-191. Abstract.

Newton JN, Swerdlow AJ, dos Santos Silva IM, Vessey MP, Grahame-Smith DG, Primatesta P, Reynolds DJM (1994). The epidemiology of carcinoid tumours in England and Scotland. British Journal of Cancer, 70(5), 939-942. Abstract.

Newton J, Goldacre M (1993). Future of small and specialist medical services. Lancet, 342(8875), 866-867. Author URL.

Newton J, Goldacre M (1993). Multiple hospital admissions in a calendar year. J Public Health Med, 15(3), 249-254. Abstract. Author URL.

Newton J, Seagroatt V (1993). Why is osteoarthritis of the hip more common on the right?. Lancet, 341(8838). Author URL.

Newton J, Goldacre M (1992). ABO blood group and gall stone disease. BMJ, 305(6847). Author URL.

FERGUSON JA, GOLDACRE MJ, NEWTON JN, DAWBER RPR (1992). An epidemiological profile of in‐patient workload in dermatology. Clinical and Experimental Dermatology, 17(6), 407-412. Abstract.

NEWTON JN (1989). PUBLIC-HEALTH CONSULTANTS. BRITISH MEDICAL JOURNAL, 299(6708), 1167-1167. Author URL.

Chapters

Newton JN, Fleming LE, Depledge MH, Bennett B, Morris G, Keast J, Gribble MO (2023). Chapter 16 Estimating the impact of oceans on human health: the value of taking a burden of disease approach. In (Ed) Oceans and Human Health, Elsevier, 473-495.

Conferences

Newton J (2019). Global Burden of Disease Study: overview and experience from England. Author URL.

Edit Profile